Prognostic value of interim FDG-PET in diffuse large cell lymphoma: Results from the CALGB 50303 clinical trial
Heiko Schöder, Mei Yin C. Polley, Michael V. Knopp, Nathan Hall, Lale Kostakoglu, Jun Zhang, Howard R. Higley, Gary Kelloff, Heshan Liu, Andrew D. Zelenetz, Bruce D. Cheson, Nina Wagner-Johnston, Brad S. Kahl, Jonathan W. Friedberg, Eric D. Hsi, John P. Leonard, Lawrence H. Schwartz, Wyndham H. Wilson, Nancy L. Bartlett
Dive into the research topics of 'Prognostic value of interim FDG-PET in diffuse large cell lymphoma: Results from the CALGB 50303 clinical trial'. Together they form a unique fingerprint.